| Real-world weight change, adherence, and discontinuation among patients with type 2 diabetes initiating glucagon-like peptide-1 receptor agonists in the UK T Weiss, L Yang, RD Carr, S Pal, B Sawhney, R Boggs, S Rajpathak, ... BMJ Open Diabetes Research and Care 10 (1), e002517, 2022 | 82 | 2022 |
| Clinical and economic burden of chronic heart failure and reduced ejection fraction following a worsening heart failure event J Butler, LM Djatche, B Sawhney, S Chakladar, L Yang, JE Brady, M Yang Advances in therapy 37, 4015-4032, 2020 | 70 | 2020 |
| Real-world adherence and discontinuation of glucagon-like peptide-1 receptor agonists therapy in type 2 diabetes mellitus patients in the United States T Weiss, RD Carr, S Pal, L Yang, B Sawhney, R Boggs, S Rajpathak, ... Patient preference and adherence, 2337-2345, 2020 | 65 | 2020 |
| Treatment patterns and clinical outcomes among patients< 65 years with a worsening heart failure event J Butler, M Yang, B Sawhney, S Chakladar, L Yang, LM Djatche European Journal of Heart Failure 23 (8), 1334-1342, 2021 | 19 | 2021 |
| Dose distribution and up‐titration patterns of metformin monotherapy in patients with type 2 diabetes K Iglay, B Sawhney, AZ Fu, G Fernandes, MF Crutchlow, S Rajpathak, ... Endocrinology, diabetes & metabolism 3 (1), e00107, 2020 | 12 | 2020 |
| Distance to glycemic goal at the time of treatment intensification in patients with type 2 diabetes mellitus failing metformin monotherapy in the United States G Fernandes, B Sawhney, H Hannachi, J Liu, T Wang, AZ Fu, K Iglay, ... Current Medical Research and Opinion 36 (5), 741-748, 2020 | 10 | 2020 |
| Cost-Effectiveness of Pembrolizumab as an Adjuvant Treatment in Colombia for Melanoma Patients with Lymph Node Involvement After Complete Resection C Lopez-Vinueza, J Urrego-Reyes, FRS Gutierrez, V Wurcel, S Zhang, ... Advances in Therapy 40 (6), 2836-2854, 2023 | 2 | 2023 |
| Time and productivity loss associated with immunotherapy infusions for the treatment of melanoma in the United States: a survey of health care professionals and patients R Aguiar-Ibáñez, E Scherrer, D Grebennik, J Cook, S Bagga, B Sawhney, ... BMC Health Services Research 23 (1), 136, 2023 | 2 | 2023 |
| 897 Infusion episode-related benefits of pembrolizumab Q6W dosing schedule for patients with melanoma treated in the adjuvant and metastatic settings in the United States (US) R Aguiar-Ibanez, E Scherrer, D Grebennik, A Khandelwal, J Cook, ... Journal for ImmunoTherapy of Cancer 9 (Suppl 2), 2021 | 1 | 2021 |
| Real world study of characteristics and outcomes of commercially insured patients with stable versus worsening chronic heart failure with reduced ejection fraction J Butler, L Djatche, B Sawhney, S Chakladar, L Yang, J Brady, M Yang Journal of the American College of Cardiology 75 (11_Supplement_1), 1014-1014, 2020 | 1 | 2020 |
| EE41 Cost-Effectiveness of Pembrolizumab as First-Line Treatment for Patients With MSI-H or dMMR Unresectable or Metastatic Colorectal Cancer From Public Perspective in Mexico D Medrano, R Acevedo, V Wurcel, M Rojas, J Nazario, R Gongora, ... Value in Health 27 (12), S61, 2024 | | 2024 |
| The Burden of Cervical Conization in Privately Insured Young and Mid-Adult Women in the United States K Saxena, B Sawhney, S Yande, N Kathe, S Chatterjee Vaccines 11 (4), 804, 2023 | | 2023 |
| RWD77 Incremental Cost Due to Major Depressive Disorder in the United States: 2016-2019 O Rohatgi, B Sawhney, N Kathe, S Tewari, R Aparasu Value in Health 25 (7), S590, 2022 | | 2022 |
| PCN235 Health-Related Quality of Life of HPV-Related Cancer Patients in the United States: 2010-2018 M Dayma, R Markan, B Sawhney, N Kathe Value in Health 24, S63-S64, 2021 | | 2021 |
| DEMOGRAPHICS, PREVALENCE AND CO-PREVALENCE OF COMORBIDITIES AMONG PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS IN THE US G Fernandes, B Sawhney, K Mirchandani, L Yang, M Crutchlow, V Vaidya, ... The Liver Meeting Digital Experience™, 2020 | | 2020 |
| 1144-P: Distribution of Prescribed Dose During the First Year of Metformin Monotherapy in the US K Iglay, B Sawhney, S Rajpathak, M Crutchlow, G Fernandes, K Khunti Diabetes 68 (Supplement_1), 2019 | | 2019 |
| 1495-P: Distance to Glycemic Target of Patients (Pts) with Type 2 Diabetes (T2D) and Established Cardiovascular Disease (eCVD) and/or Chronic Kidney Disease (CKD) Failing … G Fernandes, B Sawhney, H Hannachi, T Wang, ANN MCNEILL, K IGLAY, ... Diabetes 68 (Supplement_1), 2019 | | 2019 |
| 1496-P: Clinical Inertia in Relation to Sociodemographic Factors among Patients with Type 2 Diabetes (T2D) in the United States G Fernandes, B Sawhney, H Hannachi, T Wang, ANN MCNEILL, K Iglay, ... Diabetes 68 (Supplement_1), 2019 | | 2019 |
| 2431-PUB: Distance from Glycemic Target at the Time of Intensification in Patients with Type 2 Diabetes (T2D) Failing Metformin Dual Therapy in the United States G FERNANDES, B SAWHNEY, H HANNACHI, T WANG, ANN MCNEILL, ... Diabetes 68 (Supplement_1), 2019 | | 2019 |
| Distribution of dose and up-titration patterns for patients initiating metformin monotherapy in the UK K Iglay, B Sawhney, AZ Fug, G Fernandes, M Crutchlow, S Rajpathak, ... DIABETOLOGIA 61, S342-S342, 2018 | | 2018 |
Javed ButlerProfessor, University of Mississippi在 bswhealth.org 的电子邮件经过验证
